Back to Hood River Capital Management LLC Hood River Capital Management LLC

KRYSKRYS

Showing 8 of 25 quarters

Position history for Hood River Capital Management LLCHood River Capital Management LLC's holdings in KRYSTAL BIOTECH INC

Yes. Hood River Capital Management holds 663,375 shares of KRYS (Krystal Biotech), worth $246.6M, as of its Q2 2026 13F filing. It increased the position by 43,789 shares (+7.1%) from Q1 2026. Hood River Capital Management has held KRYS since Q2 2020, across 25 quarterly 13F filings. KRYS is 1.8% of Hood River Capital Management's reported 13F portfolio.

Current Value

$246.6M

Current Shares

663,375

Total Value Change

+$155.2M

Total Shares Change

+161,271

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
663,375
+7.1%
$246.6M1.8%$371.67
52
2026-Q1
Increased
619,586
+1.0%
$160.1M1.6%$263.80
48
2025-Q4
Increased
613,302
+1.1%
$151.2M1.7%$247.88
48
2025-Q3
Increased
606,946
+13.9%
$107.1M1.3%$176.75
54
2025-Q2
Increased
533,023
+1.6%
$73.3M1.0%$138.88
47
2025-Q1
Increased
524,644
+2.3%
$94.6M1.6%$183.92
48
2024-Q4
Increased
512,726
+2.1%
$80.3M1.2%$159.80
48
2024-Q3
Decreased
502,104
-3.6%
$91.4M1.5%$177.14
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used